Cargando…
Treating Rare Diseases in Africa: The Drugs Exist but the Need Is Unmet
Rare diseases (RD) pose serious challenges in terms of both diagnosis and treatment. Legislation was passed in the US (1983) and in EU (2000) aimed to reverse the previous neglect of RD, by providing incentives for development of “orphan drugs” (OD) for their management. Here we analyse the current...
Autores principales: | Luzzatto, Lucio, Makani, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784510/ https://www.ncbi.nlm.nih.gov/pubmed/35082665 http://dx.doi.org/10.3389/fphar.2021.770640 |
Ejemplares similares
-
Editorial: Ocular Pharmacology: Recent Breakthroughs and Unmet Needs
por: Bucolo, Claudio, et al.
Publicado: (2022) -
Unmet Needs in Pharmacological Treatment of Apathy in Alzheimer’s Disease: A Systematic Review
por: Theleritis, Christos G., et al.
Publicado: (2019) -
Editorial: The Challenge of New Therapeutic Approaches for Unmet Therapeutic Needs
por: Rosa, Arianna Carolina, et al.
Publicado: (2020) -
A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs
por: Chen, Po-Lin, et al.
Publicado: (2020) -
Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (HASTE): How to meet major health needs at a reasonable cost
por: Costa, Enrico, et al.
Publicado: (2020)